An interventional study of Strategy Training in Stroke, Adherence, Patient and Strategy Training, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 18 Years to 105 Years. Per ClinicalTrials.gov, last updated 2020-07-02.
Sponsored by University of Pittsburgh · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 25 studies in Stroke by University of Pittsburgh — 7 open to participants now, 7 under way, none of them phase 3. Stroke · University of Pittsburgh.
Among the 25 studies in Stroke by University of Pittsburgh, this one is the 11th largest by enrollment of the 23 interventional ones that give a count, is one of 2 that started in 2017, is one of 17 with no phase, and was the 11th registered.
8,258 studies on the registry are indexed under Stroke; 2,055 are open to participants now.
Browse Stroke studies →7 of the 25 studies in Stroke by University of Pittsburgh are open now, in 1 country. Recruiting first, the newest first:
University of Pittsburgh · Sites in United States
Ages 18+
University of Pittsburgh · Sites in United States
Ages 18+
University of Pittsburgh · Sites in United States
Ages 18+
University of Pittsburgh · Sites in United States
Ages 18+ · Healthy volunteers
University of Pittsburgh · Sites in United States
Ages 18+
By country, each count listing its studies:
Of the 1,415 Stroke studies recruiting now, 695 (49%) set no upper age limit and 280 (20%) stop at 75 or younger; 77 take children under 18; 195 take healthy volunteers.
This study: 18 Years to 105 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
25 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 2 started in 2017.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 32 is below the median of 49 across 6,027 interventional studies indexed under Stroke.
Median enrollment 32 across the 23 interventional studies, 911 across the 2 observational. Of the 18 that completed or were terminated, 8 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of Pittsburgh is the lead sponsor of 1,420 studies on the registry; 169 are open to participants now.
Of its 9 completed or terminated interventional studies of FDA-regulated products, 4 (44%) have results posted.
3 of the studies in Stroke by University of Pittsburgh that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05653440University of PittsburghBalancing Effortful and Errorless Learning in Naming Treatment for Aphasia | 2027-01-31 |
| NCT05653466University of PittsburghAdaptive Trial Scheduling in Naming Treatment for Aphasia | 2027-01-31 |
| NCT06758505University of PittsburghRehabilitation Strategies for Social Participation in Chronic Stroke Survivors | 2027-06 |
Add all 3 to your calendar (.ics) → With an account.
Among the 25 studies in Stroke by University of Pittsburgh, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Adherence to rehabilitation interventions is associated with functional outcomes (e.g. independence in daily activities, return of motor function) after stroke. Low adherence to rehabilitation home programs is common after stroke. Interventions delivered via mobile health applications demonstrated positive effects on adherence to health behaviors (e.g. medication routines, smoking cessation). The investigators developed the iADAPT mobile application to support adherence to Strategy Training. Strategy Training is an iterative rehabilitation intervention the promotes goal setting, planning, and self-monitoring after stroke. This study examines the effects of the iADAPT mobile health application relative to a workbook on adherence to Strategy Training after stroke.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
-Diagnosis of Stroke
Exclusion Criteria:
Participants will use the iADAPT mobile health application to supplement to in-person and remote intervention sessions.
Behavioral: Strategy Training
Participants will use a printed workbook to supplement to in-person and remote (by telephone) intervention sessions.
Behavioral: Strategy Training
Strategy training is a form of meta-cognitive instruction that trains individuals with stroke-related cognitive impairments to identify and prioritize problematic daily activities, identify the barriers impeding performance, generate and evaluate their own strategies to address barriers, and apply these skills through iterative practice.
Adherence: Observed client behavior
Number of completed activity trials in the iADAPT application or Workbook
Time frame: Baseline to 3 months
Adherence: Client-reported progress on goals.
Client rating of independence with self-selected goals (measured using Canadian Occupational Performance Measure)
Time frame: Baseline and 3 months
Adherence: Client perspectives on treatment environment
Client rating on patient-provider connection and treatment expectancy measured by Healing Encounters and Attitudes Lists
Time frame: Baseline and 3 months
Plan to share: No
No publications or documents are linked to this record.
Ran from Aug 2017 to primary completion in Jul 2019, 22 months.
Of 3,111 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 22 months is close to that.
Counting every sponsor, half of 3,255 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.